The concentration of AVP has been shown by us to be elevated in the human and lamb fetus during perinatal stress, especially hypoxia and asphyxia, with levels being greatest in association with meconium in the amniotic fluid (AN. The role of AVP in these instances is unclear; thus, we studied in fetal lambs the cardiovascular effects and clearance of infused AVP. AVP was infused into the vena cava of fetal lambs, 129-137 days gestation, a t doses of 1.94, 3.88, and 7.76 mU/min for 75 min (n=5) while monitoring fetal and maternal mean arterial pressure (MAP), heart rate (HR), and umbilical and uterine blood flows. Samples were obtained for serial determinations of fetal plasma and AF AVP in 3 studies. Fetal plasma AVP rose from 2.0 t .02 uU/ml (Meant SE) to 12 to 67 uU/ml a t 60 min without changes in arterial blood gases. AF AVP increased a t 60 and 120 min post-infusion, but did not correlate with plasma levels. Fetal MAP a t 60 min rose 16 to 24%* while HR fell 9 to 43%*; both responses were dose dependent. Umbilical and uterine blood flows and maternal MAP and HR did not change. Of note, meconium stained AF occurred in association with intermediate and high rates of AVP infusions. The T of AVP in fetal plasma was 14 t 2.5 min and the clearance was 51 i1f8 ml/min-kg. We conclude that AVP 1) causes a rise in MAP and fall in HR that relates to circulating levels of AVP, suggesting AVP may mediate these changes during episodes of fetal stress, and 2) may be responsible for the expulsion of meconium into the AF during such episodes. *p < .O1 Blood insulin gicagon and GH were measured a t 0-12,13-24,25-48, 49-72 and 73-96 hours of aae. and were com~ared to birth weiaht above or below 1000 gm, gestational"age above and bdlow 32 weeks, size appropriate or small for gestational age, and the presence of chronic in-uterostress, perinatal asphyxia, central nervous system hemorrhage, and mortality in 31 premature infants. Plasma (P) insulin very often was undetectable (85.2' h) gluca on was detected in most of the sam les (75.4%). P. levels of ! : : E n and g$ucagon were not related to clinicafconditions other than to birth weights. lnfants weighing 1000 m or less more often had measurable insulin and glucagon as compared to tilose weighing over 1000 gm. This finding was noted only when they were appropriate for their gestational age. Premature infants with adequate k-utew growth seemed to have ade uate insulin secretion before they reached 1000 gm and were ready for thequture fetal growth. When the actual growth spurt took place, these infants often did not have circulating insulin. These data suggest that circulating insulin detected may not be the biologically active form. In contrast to insulin, GH did not seem to be related to fetal growth. Infants with birth wei hts f 1000 gm or less and perinatal asphyxia had GH that were often 2.3 n$l or less. All ~nfants with GH 2.5 ng/ml or less died. No infant with c ronic in-utero stress had GH 2.5 ng/ml or less. These data support the conce t that severe insult may shut off GH secretion as in hypopituitarism, and caronic stress may increase GH secretion. Pharmacological induction of muscle paralysis with PB i s frequently used i n the newborn to f a c i l i t a t e a r t i f i c i a l ventilation. Cardiovascular responses t o t h i s drug have not been as well documented i n the neonate as i n the adult. Sixteen newborn p i g l e t s (wt 800-2300 gms) were anesthetized with ketarnine (IM) and placed on a Bourns LS-105 v e n t i l a t o r . Heart r a t e , s y s t o l i c , d i a s t o l i c and MAP were continuously monitored. PB was given I V i n varying dosages (.03-.72 mg/kg)for induction of complete paralysis. Acidbase imbalance ( p~ 7.03-7.65) was produced by a l t e r i n g v e n t i l a t o r s e t t i n g s and by l a c t i c acid infusion. Fifty-eight percent of PB injections resulted i n an increased MAP (T? 12.9 mmHg),9% lowered MAP(+? 16 mmHg)and i n the remaining 32%,MAP continued unchanged. The following variables were a l s o analyzed: weight, drug dosage, blood OH and change i n heart r a t e (HR). Analysis of variance revealed t h a t HR changes were the only s t a t i s t i c a l l y s i g n i f i c a n t variable (pC05). A s i g n i f i c a n t r i s e i n HR was noted with e i t h e r an increase or decrease i n MAP, while the HR remained r e l a t i v e l y constant when MAP was unchanged. In adults, PB increases HR and MAP; however, i n the newborn p i g l e t , the response to PB i s variable. Alterations i n MAP have s i g n i f i c a n t e f f e c t s on tissue-organ blood flow. I f the variable HR and MAP responses t o PB seen i n the newborn animal model can be extrapolated t o humans, careful monitoring of cardiovascular function is advisable i n neonates undergoing muscle paralysis. Factors possibly associated with increased use o f drug e x ps u r e i n a NICU were evaluated prospectively i n a l l neonates admitted to NICU s i n c e Feb 1977. -graphic, clinical and laboratory data on a l l babies (&) were recorded by a physician/nurse m n i t o r team and stored i n the wmputer. Analyses o f d a t a fmm t h e f i r s t 461 neonates ( b t wgt range 734-4850 g , gestational age (CA) 24-43 wks) show t h a t 128 d i f f e r e n t druqs were used. 76.1% o f babies received 1 to 35 drugs (excluding routine V i t K and AgN03) with a m a n exposure o f 4.6/Bb. Babies with CA <32 wks (18%) had 3X mre drug e m s u r e than those with G4 >32 wks (9.7 vs 3.4 drugs/&).
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Blood insulin gicagon and GH were measured a t 0-12,13-24,25-48, 49-72 and 73-96 hours of aae. and were com~ared to birth weiaht above or below 1000 gm, gestational"age above and bdlow 32 weeks, size appropriate or small for gestational age, and the presence of chronic in-uterostress, perinatal asphyxia, central nervous system hemorrhage, and mortality in 31 premature infants. Plasma (P) insulin very often was undetectable (85.2' h) gluca on was detected in most of the sam les (75.4%). P. levels of ! : : E n and g$ucagon were not related to clinicafconditions other than to birth weights. lnfants weighing 1000 m or less more often had measurable insulin and glucagon as compared to tilose weighing over 1000 gm. This finding was noted only when they were appropriate for their gestational age. Premature infants with adequate k-utew growth seemed to have ade uate insulin secretion before they reached 1000 gm and were ready for thequture fetal growth. When the actual growth spurt took place, these infants often did not have circulating insulin. These data suggest that circulating insulin detected may not be the biologically active form. In contrast to insulin, GH did not seem to be related to fetal growth. Infants with birth wei hts f 1000 gm or less and perinatal asphyxia had GH that were often 2.3 n$l or less. All ~nfants with GH 2.5 ng/ml or less died. No infant with c ronic in-utero stress had GH 2.5 ng/ml or less. These data support the conce t that severe insult may shut off GH secretion as in hypopituitarism, and caronic stress may increase GH secretion. Pharmacological induction of muscle paralysis with PB i s frequently used i n the newborn to f a c i l i t a t e a r t i f i c i a l ventilation. Cardiovascular responses t o t h i s drug have not been as well documented i n the neonate as i n the adult. Sixteen newborn p i g l e t s (wt 800-2300 gms) were anesthetized with ketarnine (IM) and placed on a Bourns LS-105 v e n t i l a t o r . Heart r a t e , s y s t o l i c , d i a s t o l i c and MAP were continuously monitored. PB was given I V i n varying dosages (.03-.72 mg/kg)for induction of complete paralysis. Acidbase imbalance ( p~ 7.03-7.65) was produced by a l t e r i n g v e n t i l a t o r s e t t i n g s and by l a c t i c acid infusion. Fifty-eight percent of PB injections resulted i n an increased MAP (T? 12.9 mmHg),9% lowered MAP(+? 16 mmHg)and i n the remaining 32%,MAP continued unchanged. The following variables were a l s o analyzed: weight, drug dosage, blood OH and change i n heart r a t e (HR). Analysis of variance revealed t h a t HR changes were the only s t a t i s t i c a l l y s i g n i f i c a n t variable (pC05). A s i g n i f i c a n t r i s e i n HR was noted with e i t h e r an increase or decrease i n MAP, while the HR remained r e l a t i v e l y constant when MAP was unchanged. In adults, PB increases HR and MAP; however, i n the newborn p i g l e t , the response to PB i s variable. Alterations i n MAP have s i g n i f i c a n t e f f e c t s on tissue-organ blood flow. I f the variable HR and MAP responses t o PB seen i n the newborn animal model can be extrapolated t o humans, careful monitoring of cardiovascular function is advisable i n neonates undergoing muscle paralysis.
DEVELOPMENTAL PHARMACOLOGY
Factors possibly associated with increased use o f drug e x ps u r e i n a NICU were evaluated prospectively i n a l l neonates admitted to NICU s i n c e Feb 1977. -graphic, clinical and laboratory data on a l l babies (&) were recorded by a physician/nurse m n i t o r team and stored i n the wmputer. Analyses o f d a t a fmm t h e f i r s t 461 neonates ( b t wgt range 734-4850 g , gestational age (CA) 24-43 wks) show t h a t 128 d i f f e r e n t druqs were used. 76.1% o f babies received 1 to 35 drugs (excluding routine V i t K and AgN03) with a m a n exposure o f 4.6/Bb. Babies with CA <32 wks (18%) had 3X mre drug e m s u r e than those with G4 >32 wks (9.7 vs 3.4 drugs/&).
GA and b t w g t were inversely r e l a t e d with drug exposure ( n h r o f drugs/Bb) . Drug exposure was g r e a t e r i n disease s t a t e s m r e w m n l y associated with prematurity; 14.2 drugs/Bb i n PDA, 16.8 i n necrotizing e n t e r o c o l i t i s , 14.5 i n pers i s t e n t f e t a l c i r c u l a t i o n , 12.5 i n renal f a i l u r e , 13.1 i n l i v e r disease. 17 d i f f e r e n t antimicrobials were used i n 47.7% o f Bb, d i u r e t i c s i n 17.4%, cardiovascular drugs i n 9.8%, s t e r o i d s i n 4.3% and sedatives and n a r m t i c s f o r p a l l i a t i o n i n 13.0%. Wan b t wgts and GA were s i g n i f i c a n t l y lower i n babies who received antimicrobials, d i u r e t i c s , and mthylxanthines . Data underscore the necessity o f requisite p h a m c o l o g i c s t u d i e s i n the low b t wgt i n f a n t s who are a t g r e a t e r r i s k o f drug e x p s u r e .
EFFECT OF CAFFEINE ON CONTROL OF BREATHING IN

NEAR-MISS SUDDEN INFANT DEATH SYNDROME ( s I D s )
J a c o b V. A r a n d a , J o n a t h a n D a v i s , T o m r i s Turmen, D a n i e l l e G r o n d i n , R a e z e l l e Zinman. D e p t s o f P e d i a t r i c s , P h a r m a c o l & T h e r . M c G i l l U n i v -M o n t r e a l C h i l d r e n ' s Hosp. R e s . I n s t . M o n t r e a l , Q u e b e c , Canada.
A b n o r m a l i t i e s i n c o n t r o l o f b r e a t h i n g h a v e b e e n a ss o c i a t e d w i t h ' n e a r -m i s s SIDS. S i n c e c a f f e i n e (C) i s a r e s p i r a t o r y s t i m u l a n t , i t s e f f e c t o n b r e a t h i n g p a t t e r n was e v a l u a t e d i n 1 2 i n f a n t s w i t h n e a r -m i s s SIDS. Mean b i r t h w e i g h t s ('SE), g e s t a t i o n a l a n d p o s t n a t a l a g e w e r e 3 . 1 t 3 . 0 k g , 37.0'1.1 wks, a n d 7 . 9 t 1 . 7 wks, r e sp e c t i v e l y . V e n t i l a t o r y r e s p o n s e s w e r e m e a s u r e d w i t h a f a c e mask a t t a c h e d t o a p n e u m o t a c h o m e t e r t o m e a s u r e f l o w a n d i n t e g r a t e d t o y i e l d volume b e f o r e a n d 1 h o u r a f t e r c a f f e i n e c i t r a t e ( 2 0 mg/kg I V ) . A n a l y s i s o f d a t a b e f o r e a n d a f t e r c a f f e i n e shows a s i g n i f i c a n t i n c r e a s e i n v e n t i l a t i o n (Mean t S E = 3 5 0 . 1 t 4 2 . 7 t o 4 4 4 . 2 i 3 9 . 3 m l / kq/min, p < 0 . 0 0 5 ) ; t i d a l volume ( 6 . 8 t 0 . 6 t o 8 . 4 t 0 . 8 ml/ k g , p < 0 . 0 0 5 ) a n d mean i n s p i r a t o r y f l o w (VT/TI = 1 2 . 2 t 1 . 2 t o 1 5 . 9 i 1 . 2 m l / k g / s e c , p = 0 . 0 0 1 ) . I n c o n t r a s t , n o c h a n g e s w e r e n o t e d i n i n s p i r a t o r y t i m e ( T I ) , e x p i r a t or y t i m e o r t o t a l c y c l e c u r a t i o n . T h e s e e f f e c t s w e r e obs e r v e d w i t h p l a s m a c o n c e n t r a t i o n s o f (C) ( m e a s u r e d b y HPLC) r a n q i n g f r o m 8 t o 20 mg/l. D a t a s u g g e s t t h a t c a ff e i n e i n c r e a s e s v e n t i l a t i o n m a i n l y b y i n c r e a s i n g c e nt r a l i n s p i r a t o r y d r i v e a n d n o t b y e f f e c t i v e t i m i n g (TI/TTQT) a n d s u g g e s t p o s s i b l e e f f i c a c y o f c a f f e i n e i n n e a r -m l s s SIDS. . 8 * = d i f f e r e n t f r m control a t p < 0.01.
Within 30 minutes, Fe produced a s i g n i f i c a n t reduction i n MCF as evidenced by decreased CO and RVF, with no reduction in f i l l i n g Dressure (RAP). Fe oroduced myocardial depression independent of acidosis. The d i r e c t depressant e f f e c t of Fe on MCF could be responsible, in p a r t , f o r the shock seen in acute Fe ingestion. These findings may provide the basis f o r new aporoaches t o the treatment of shock in Fe poisoning.
